Related Experiment Video
Updated: May 13, 2026
Preventing the Spread of Malaria and Dengue Fever Using Genetically Modified Mosquitoes
Published on: July 4, 2007
Harnessing antimicrobial peptides to engineer mosquito immunity against emerging vector-borne diseases
Yuchen Wang1, Jianan Hao2, Yixuan Huang2
1Department of Inspection and Quarantine, Shanghai Customs University, Shanghai, China.
Abstract:
A variety of emerging and re-emerging mosquito-borne infectious diseases, including malaria, dengue, chikungunya, and Zika are expanding their geographic range and imposing an escalating burden on global public health. Effective vaccines or targeted therapeutics remain unavailable for most of these diseases. Antimicrobial peptides (AMPs), a class of naturally occurring polypeptides, exhibit potent antiparasitic, antiviral, and antibacterial activities. Their unique modes of action, low toxicity, high target specificity, and broad-spectrum activity, make them as promising candidates for therapeutic development. Here, we review AMPs with demonstrated activity against mosquito-borne pathogens and evaluate their translational potential. We further outline next-generation intervention strategies that leverage artificial-intelligence-driven discovery, circular RNA expression platforms, CRISPR-based gene editing, engineered symbionts, and nanotechnology-enabled delivery systems, providing a roadmap for integrating AMP-based approaches into future public-health strategies.
Insights
Antimicrobial peptides (AMPs) show promise against mosquito-borne diseases like malaria and Zika, where vaccines are lacking. Future strategies integrate AMPs with advanced technologies for public health.
Area of Science:
- Infectious Diseases
- Biotechnology
- Public Health
Background:
- Mosquito-borne diseases (e.g., malaria, dengue, Zika) are a growing global health threat.
- Effective vaccines and therapeutics are largely unavailable for these diseases.
- Antimicrobial peptides (AMPs) possess broad-spectrum antimicrobial, antiparasitic, and antiviral properties.
Purpose of the Study:
- To review AMPs with proven activity against mosquito-borne pathogens.
- To evaluate the therapeutic potential and translational viability of AMPs.
- To outline advanced strategies for integrating AMPs into public health interventions.
Main Methods:
- Literature review of AMPs targeting mosquito-borne pathogens.
- Evaluation of AMPs' characteristics: mode of action, toxicity, specificity, and spectrum.
- Exploration of next-generation strategies: AI-driven discovery, RNA platforms, gene editing, engineered symbionts, and nanotechnology.
Main Results:
- AMPs demonstrate significant activity against a range of mosquito-borne disease agents.
- AMPs exhibit favorable properties for therapeutic development, including low toxicity and high specificity.
- Integration of AMPs with novel technologies offers a promising future for disease control.
Conclusions:
- Antimicrobial peptides represent a viable therapeutic candidate for combating mosquito-borne infectious diseases.
- Advanced technologies are crucial for realizing the full potential of AMP-based interventions.
- A strategic integration of AMPs and innovative platforms can enhance future public health efforts against vector-borne diseases.
